Navigation Links
Mayo Clinic Proceedings: A Comprehensive Review of Addiction to Prescription Painkillers Among Patients and Physicians
Date:7/7/2009

ROCHESTER, Minn., July 7 /PRNewswire-USNewswire/ -- Chemical dependency and recovery in patients and physicians are closely examined in a series of articles and editorials in the July 2009 issue of Mayo Clinic Proceedings. The subject is especially timely. As the immense challenges, including potential tragedies, of prescription chemical addiction and abuse are being discussed, these articles offer crucial overview, direction and optimism.

Addiction to and abuse of prescription opioid drugs are prevalent, and they exact an immense toll on patients, physicians and society, according to Steven Passik, Ph.D., Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, in "Issues in Long-Term Opioid Therapy: Unmet Needs, Risks, and Solutions."

Opioid drugs have been used by humans for thousands of years and are the longest continuously used class of medications, explains William Lanier, M.D., editor-in-chief of Mayo Clinic Proceedings. Dr. Lanier and Evan Kharasch, M.D., Ph.D., Department of Anesthesiology, Washington University in St. Louis, authored the editorial "Contemporary Clinical Opioid Use: Opportunities and Challenges." It summarizes the recent increased interest in this drug category.

Opioid medications are chemicals that work by binding to specific receptors, particularly in the nervous system and gastrointestinal tract; decrease perception of pain and reaction to pain; and increase pain tolerance. Side effects include sedation, respiratory depression and constipation. When opioid consumption is ongoing, physical dependence can and will develop. This, in turn, can lead to problematic withdrawal upon abrupt discontinuation of medication. Dependence, coupled with the feeling of euphoria these drugs can produce, leads to abuse.

According to Dr. Lanier, the recent growing interest in opioids stems from fi
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. June 2009 Mayo Clinic Womens HealthSource Highlights Summer Skin Problems, Low Vision and Pilates
2. Alcon Commences Phase 2 Clinical Trial of NovaBays NVC-422 for Viral Conjunctivitis
3. BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
4. Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
5. New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
6. Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases
7. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
8. Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies
9. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
10. West Wireless Health Institute Teams with Corventis for its First Multicenter, Randomized Clinical Trial
11. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...a/--ChindexInternational,Inc.,("Chindex")(Nasdaq: ...n,healthcareproductsandservicesinthePeople,sRepubl...he21stAnnualPiperJaffray,"Unplugged"HealthCareConf...eHotel. , Managementiscurrentlyscheduledtopre...e-on-onemeetingsthroughouttheday.Awebcast,ofthepre...
(Date:11/24/2009)...ll/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS )anno...frayHealthcareConferenceonTuesday,December1,2009at...tTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Presiden...rviewofAnadysanditsclinicaldevelopmentprograms,ANA...simultaneouslywebcastandcanbeaccessedontheInvestor...
(Date:11/24/2009)...-ZargisMedicalCorp.,asubsidiaryofSpeedusCorp.(Nasd...(NYSE: SI ),todayannouncedthatitsZargisCardioscand...TheEarlyShow duringasegmentinwhichMarkJannot,theed...productsfromthepublication,s2009"BestofWhat,sNew"a...ionmorningnewstalkshowbroadcastbyCBSfromNewYorkCit...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Cystic Fibrosis Treatment May Cause Hearing Loss 50673 1Cardinal Health Appoints Bruce Downey to Board of Directors 3B John McCoy Retires From Board After 22 Years 50670 1Cardinal Health Appoints Bruce Downey to Board of Directors 3B John McCoy Retires From Board After 22 Years 50670 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3
...mmary: Proprietary DNA delivery technology enables...cells - reduces,atherosclerosis progression in mou...WIRE)--Mar 26, 2007 - Research conducted,at Clevel...lege of,Cardiology,s 58th Annual Scientific Sessio...ing the anti-inflammatory protein,interferon-beta ...
...ISIS 301012 coadministered with statins for only f...the levels achieved with,statins alone, with simil..., NEW ORLEANS and CARLSBAD, Calif., March 26, 2007...nc. announced new,results from its Phase 2 clinica... presented today at the of Cardiology,Annual Scien...
Other Medicine Technology:Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 2Interferon Beta DNA Treatment Delivered with Ichor Technology,Reduces Atherosclerosis Progression in Mice 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9
(Date:11/25/2009)...swire-USNewswire/--TheAmericanAssociationforHomeca...S.2128,whichisdesignedtosubstantiallyimprovetoolsa...llwasintroducedbySen.GeorgeLeMieux(R-Fla.). ,, ...AssociationforHomecareoutlinedinits13-pointanti-fr...sinFebruary.Thoseprovisionsincludecallingforreal-t...
(Date:11/25/2009)...at can occur in children with autism and related c...t includes medication combined with a structured t...versity researchers and their colleagues. , Pub...of the American Academy of Child and Adolescent Ps... Institute of Mental Health (NIMH) Research Units ...
(Date:11/25/2009)...ve expands to include cost-effective, sustainable ...thcare professionals in developing world. , ... 25, 2009 -- Elluminate, Inc. , the leader in we...hat support 21st century teaching, learning, and c...ce initiative was awarded iNACOL,s first-ever Ou...
(Date:11/25/2009)...Newswire/--TwomoreH1N1vaccineclinicshavebeenschedu...ntyHealthDepartmentannouncedtoday.Theyarebeingoffe...rkinSterlingHeights. ,, TheDec.3clinicwillbehel....Thethimerosol-freeversionoftheinjectablevaccinewi...ectableandnasalsprayimmunizationwillbeoffered.Preg...
(Date:11/25/2009)...gresstoImproveOverallOutcomesforLungCancer ,,...,LungCancerAlliance-California(LCA-CA)issuedits2nd...anassessmentofprogressbeingmadeagainstthislethaldi...CancerAlliance(LCA),theonlynationalorganizationded...plelivingwithoratriskforlungcancer. ,, (Photo: ...
Breaking Medicine News(10 mins):Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Lung Cancer Alliance-California Releases 2nd Annual State-Specific Report Card On Lung Cancer 2
...ld Allow Condom Distribution in CA Correctional,Fa...lifornia HIV Advocacy Coalition (SCHAC) and the Ca... on Tuesday, October 2, at 10:00 a.m. (in front,of...y Act" (Swanson, D, Oakland), which will help redu...
...stored normal blood pressure, study finds , ...n study has identified overweight as a direct caus...up to half of overweight people can bring down blo... Dr. Roberto Fogari, professor of medicine at the ...
...to warn Americans about risks of indoor tanning de...rtant step,which may help reduce significantly the...Bush yesterday signed the Tanning Accountability a... directs the U.S. Food and Drug Administration (FD...
...as An inflammatory eye condition that is one of t...ated much more effectively and easily thanks to a ...ory rats, scientists at the University of Texas Me... outer surface of the eyeball and includes the iri...
... be Cut; Plan Changes Will Reduce Cost Increases b... HARRISBURG, Pa., Sept. 28 The Office of,Administ... Retired,Employees Health Program (REHP) that will...challenges facing,employers across the country," S...
...2007 (Aliso Viejo, CA) Ossur, a trusted and globa...etic innovations than any other company in the fie...s the winner of a 2007 da Vinci Award. , The PR...lectronics, mechanics, and human physiology that r...
Other Medicine News:Health News:Community Leaders to Host Press Event at L.A. Central Jail Urging Governor to Sign AB 1334 2Health News:Weight Loss Can Control Hypertension 2Health News:Weight Loss Can Control Hypertension 3Health News:American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act 2Health News:New discovery may improve treatment of one of the world's leading causes of blindness 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 3Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 4Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 5Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 6Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 7Health News:Ossur's Proprio Foot nets the 2007 da Vinci Award 2
Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up
Full Handle Laseredge Implant Blade Knife, 4.0 mm angled bevel up
Full Handle Laseredge Crescent Blade Knife, angled bevel down
Medicine Products: